Relationship of extent and nature of dysfunctional myocardium to brain natriuretic peptide in patients with ischemic left ventricular dysfunction

International Journal of Cardiovascular Imaging

Volumn 21, Issue 2-3, 2005, Pages 295-300

  Nelson, Charles A ^a   Case, Colin ^a   McCrohon, Jane ^b   Marwick, Thomas H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

Echocardiography; Magneticresonance imaging; Myocardial infarction; Natriuretic peptide; Stress; Ventricular dysfunction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; DOBUTAMINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; CORRELATION FUNCTION; CREATININE CLEARANCE; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL; HEART MUSCLE ISCHEMIA; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MYOCARDIAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BLOOD LEVEL; RADIOCARDIOGRAPHY;

EID: 21244450708     PISSN: 15695794     EISSN: 18758312     Source Type: Journal    
DOI: 10.1007/s10554-004-3565-5     Document Type: Article

References (27)

1. W Friedl J Mair S Thomas M Pichler B. Puschendorf 1999 Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise Clin Chim Acta 281 121-126 10.1016/S0009-8981(98)00217-4 1:CAS:528:DyaK1MXhvVCms7k%3D 10217633
2. A Luchner JC Burnett Jr M Jougasaki HW Hense IM Heid F Muders 2000 Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population J Hypertens 18 1121-1218 10.1097/00004872-200018080-00018 1:CAS:528:DC%2BD3cXmsVWhsLs%3D 10954005
3. TA McDonagh SD Robb DR Murdoch JJ Morton I Ford CE Morrison et al. 1998 Biochemical detection of left-ventricular systolic dysfunction Lancet 351 9-13 1:STN:280:DyaK1c%2FpsFSjtQ%3D%3D 9433422
4. BA Groenning JC Nilsson L Sondergaard F Pedersen J Trawinski M Baumann et al. 2002 Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations Am Heart J 143 923-99 1:CAS:528:DC%2BD38XltFartbs%3D 12040359
5. JC Nilsson BA Groenning G Nielsen T Fritz-Hansen J Trawinski PR Hildebrandt et al. 2002 Left ventricular remodeling in the first year after acute myocardial infarction and the predictive value of N-terminal pro brain natriuretic peptide Am Heart J 143 696-702 1:CAS:528:DC%2BD38Xkt1CqsL4%3D 11923808
6. BA Groenning JC Nilsson L Sondergaard A Kjaer HB Larsson PR. Hildebrandt 2001 Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations Eur J Heart Fail 3 699-708 1:CAS:528:DC%2BD3MXovVCmsb0%3D 11738222
7. C Nelson J McCrohon F Khafagi S Rose R Leano TH. Marwick 2004 Impact of scar thickness on the assessment of viability using dobutamine echocardiography and thallium single-photon emission computed tomography: A comparison with contrast-enhanced magnetic resonance imaging J Am Coll Cardiol 43 1248-1256 15063438
8. M Vogeser K. Jacob 2001 B-type natriuretic peptide (BNP) - validation of an immediate response assay Clin Lab 47 29-33 1:CAS:528:DC%2BD3MXhtF2htb0%3D 11214220
9. DW Cockcroft MH. Gault 1976 Prediction of creatinine clearance from serum creatinine Nephron 16 31-41 1:STN:280:CSmD2srptFU%3D 1244564
10. M Elseviers G Verpooten M De Broe G. Debacker 1987 Interpretation of creatinine clearance The Lancet 329 457
11. DM. Regen 1990 Calculation of left ventricular wall stress Circ Res 67 245-252 1:STN:280:By%2BA38bmslc%3D 2198115
12. WF Armstrong PA Pellikka T Ryan L Crouse WA. Zoghbi 1998 Stress echocardiography: Recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography J Am Soc Echocardiogr 11 97-104 1:STN:280:DyaK1c7kvVClsA%3D%3D 9487482
13. TD Miller AM Weissler TF Christian KR Bailey RJ. Gibbons 1997 Quantitative measures of regional asynergy add independent prognostic information to left ventricular ejection fraction in patients with prior myocardial infarction Am Heart J 133 640-647 1:STN:280:ByiA2czos1A%3D 9200391
14. IS Anand VG Florea L. Fisher 2002 Surrogate end points in heart failure J Am Coll Cardiol 39 1414-1421 11985901
15. H Yasue M Yoshimura H Sumida K Kikuta K Kugiyama M Jougasaki et al. 1994 Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 195-203 1:CAS:528:DyaK2cXmtVaitbw%3D 8025996
16. Y Mizuno M Yoshimura H Yasue T Sakamoto H Ogawa K Kugiyama et al. 2001 Aldosterone production is activated in failing ventricle in humans Circulation 103 72-77 1:CAS:528:DC%2BD3MXhtFemurw%3D 11136688
17. KT Jensen J Carstens P Ivarsen EB. Pedersen 1997 A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases Scand J Clin Lab Invest 57 529-540 1:STN:280:DyaK1c%2FhtFSisQ%3D%3D 9350073
18. MM Redfield RJ Rodeheffer SJ Jacobsen DW Mahoney KR Bailey JC Burnett Jr. 2002 Plasma brain natriuretic peptide concentration: Impact of age and gender J Am Coll Cardiol 40 976-982 1:CAS:528:DC%2BD38Xns1OmsLc%3D 12225726
19. I Loke IB Squire JE Davies LL. Ng 2003 Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate Euro. J. Heart Failure 5 599-606 1:CAS:528:DC%2BD3sXos1Olu70%3D
20. PM Mottram R Leano TH. Marwick 2003 Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function Am J Cardiol 92 1434-1438 1:CAS:528:DC%2BD3sXps1Grurk%3D 14675580
21. FDR. Hobbs 2002 Unmet need for diagnosis of heart failure: The view from primary care Heart 88 9ii-11
22. M Tanaka M Hiroe T Nishikawa T Sato F. Marumo 1994 Cellular localization and structural characterization of natriuretic peptide-expressing ventricular myocytes from patients with dilated cardiomyopathy J Histochem Cytochem 42 1207-1214 1:STN:280:ByuA2c3ntFw%3D 8064128
23. GT Altemose V Gritsus V Jeevanandam B Goldman KB. Margulies 1997 Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy J Heart Lung Transplant 16 765-773 1:STN:280:ByiH3c7ksFc%3D 9257259
24. K Marumoto M Hamada M Aburaya K. Hiwada 1995 Augmented secretion of atrial and brain natriuretic peptides during dynamic exercise in patients with old myocardial infarction Jpn Circ J 59 715-724 1:STN:280:BymA2M3psFI%3D 8747761
25. P Mair J Mair J Bleier C Hormann D Balogh B. Puschendorf 1997 Augmented release of brain natriuretic peptide during reperfusion of the human heart after cardioplegic cardiac arrest Clin Chim Acta 261 57-68 1:CAS:528:DyaK2sXjvVWmtLg%3D 9187505
26. JP Goetze C Christoffersen M Perko H Arendrup JF Rehfeld J Kastrup et al. 2003 Increased cardiac BNP expression associated with myocardial ischemia Faseb J 17 1105-1107 1:CAS:528:DC%2BD3sXktlyqt74%3D 12709407
27. E Morita H Yasue M Yoshimura H Ogawa M Jougasaki T Matsumura et al. 1993 Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction Circulation 88 82-91 1:STN:280:ByyA3cnotlM%3D 8319360